Cefadroxil 13C6

[13C6]-Cefadroxil is a labeled form of Cefadroxil, a first-generation cephalosporin antibiotic used to treat bacterial infections. This labeled form contains six stable carbon-13 isotopes, which allows for precise tracking and analysis in biological systems. The usage of [13C6]-Cefadroxil is mainly in pharmacokinetic studies and drug metabolism research. It is used to determine the absorption, distribution, metabolism, and excretion of Cefadroxil in the body. Researchers can also use this labeled form to study drug-drug interactions, protein binding, and other pharmacological properties of Cefadroxil in vivo and in vitro. Chemically, [13C6]-Cefadroxil is a semi-synthetic antibiotic that inhibits bacterial cell wall synthesis. It works by binding to penicillin-binding proteins (PBPs) in bacteria, which interferes with the formation of peptidoglycan, an essential component of bacterial cell walls. This disruption ultimately leads to bacterial cell death. In terms of safety, [13C6]-Cefadroxil is considered safe for use in research studies. However, like all antibiotics, it can cause side effects such as diarrhea, nausea, and skin rashes. It is important to follow proper handling and disposal protocols when working with this substance to prevent any harmful effects to researchers or the environment. Overall, [13C6]-Cefadroxil is a valuable tool in pharmacokinetic and drug metabolism studies, providing valuable insights into the mechanisms of action and distribution of Cefadroxil in the body.